| Cardiovascular safety of tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a multi‐database cohort study SC Kim, DH Solomon, JR Rogers, S Gale, M Klearman, K Sarsour, ... Arthritis & rheumatology 69 (6), 1154-1164, 2017 | 201 | 2017 |
| Bisphosphonates and risk of cardiovascular events: a meta-analysis DH Kim, JR Rogers, LA Fulchino, CA Kim, DH Solomon, SC Kim PloS one 10 (4), e0122646, 2015 | 154 | 2015 |
| Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims RJ Desai, A Sarpatwari, S Dejene, NF Khan, J Lii, JR Rogers, SK Dutcher, ... PLoS medicine 16 (3), e1002763, 2019 | 95 | 2019 |
| Adaptation and validation of the combined comorbidity score for ICD-10-CM JW Sun, JR Rogers, Q Her, EC Welch, CA Panozzo, S Toh, JJ Gagne Medical care 55 (12), 1046-1051, 2017 | 91 | 2017 |
| Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions SV Wang, SK Sreedhara, REPEAT Initiative [includes JR Rogers], ... Nature communications 13 (1), 1-11, 2022 | 48 | 2022 |
| No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: a multi-database cohort study SC Kim, DH Solomon, JR Rogers, S Gale, M Klearman, K Sarsour, ... Seminars in arthritis and rheumatism 48 (3), 399-405, 2018 | 42 | 2018 |
| Data mining for adverse drug events with a propensity score matched tree-based scan statistic SV Wang, JC Maro, E Baro, R Izem, I Dashevsky, JR Rogers, M Nguyen, ... Epidemiology (Cambridge, Mass.) 29 (6), 895, 2018 | 40 | 2018 |
| Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study RJ Desai, A Sarpatwari, S Dejene, NF Khan, J Lii, JR Rogers, SK Dutcher, ... bmj 361, 2018 | 37 | 2018 |
| Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention SV Wang, JR Rogers, Y Jin, DW Bates, MA Fischer Journal of the American Medical Informatics Association 24 (2), 339-344, 2017 | 37 | 2017 |
| Mandatory disclaimers on dietary supplements do not reliably communicate the intended issues AS Kesselheim, J Connolly, J Rogers, J Avorn Health Affairs 34 (3), 438-446, 2015 | 32 | 2015 |
| Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review JR Rogers, J Lee, Z Zhou, YK Cheung, G Hripcsak, C Weng Journal of the American Medical Informatics Association 28 (1), 144-154, 2021 | 31 | 2021 |
| Ensembles of natural language processing systems for portable phenotyping solutions C Liu, CN Ta, JR Rogers, Z Li, J Lee, AM Butler, N Shang, FSP Kury, ... Journal of biomedical informatics 100, 103318, 2019 | 29 | 2019 |
| The relative benefits of claims and electronic health record data for predicting medication adherence trajectory JM Franklin, C Gopalakrishnan, AA Krumme, K Singh, JR Rogers, ... American heart journal 197, 153-162, 2018 | 29 | 2018 |
| Deep learning for rare disease: A scoping review J Lee, C Liu, J Kim, Z Chen, Y Sun, JR Rogers, WK Chung, C Weng Journal of Biomedical Informatics, 104227, 2022 | 25 | 2022 |
| Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials JH Kim, CN Ta, C Liu, C Sung, AM Butler, LA Stewart, L Ena, JR Rogers, ... Journal of the American Medical Informatics Association 28 (1), 14-22, 2021 | 21 | 2021 |
| Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data JR Rogers, C Liu, G Hripcsak, YK Cheung, C Weng JAMA Network Open 4 (4), e214732-e214732, 2021 | 20 | 2021 |
| Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis C Liu, J Lee, C Ta, A Soroush, JR Rogers, JH Kim, K Natarajan, J Zucker, ... JMIR Public Health and Surveillance 8 (5), e35311, 2022 | 19 | 2022 |
| Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation SV Wang, JR Rogers, Y Jin, D DeiCicchi, S Dejene, JM Connors, ... BMJ quality & safety 28 (10), 835-842, 2019 | 18 | 2019 |
| Understanding the nature and scope of clinical research commentaries in PubMed JR Rogers, H Mills, LV Grossman, A Goldstein, C Weng Journal of the American Medical Informatics Association 27 (3), 449-456, 2020 | 14 | 2020 |
| Survey of living organ donors’ experience and directions for process improvement T Li, MK Dokus, KN Kelly, N Ugoeke, JR Rogers, G Asham, VA Sharma, ... Progress in Transplantation 27 (3), 232-239, 2017 | 12 | 2017 |
